Hepion PharmaceuticalsHEPA
13F holders, Q2 2025 (June 30)1holders −21
1new positions
0sold out
$0.00avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding Hepion Pharmaceuticals Inc. (HEPA) in their 13F filings, down 21 from Q4 2024. 1 opened new positions and 0 sold out. The largest holder was Harbor Investment Advisory, LLC ($0).
- Company
- Hepion Pharmaceuticals Inc.
- CUSIP
- 426897302
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q2 2025: 1 shares bought, net +1 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Harbor Investment Advisory, LLC | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is HEPA's weight in each manager's 13F, not the share of Hepion Pharmaceuticals Inc. the manager owns.